TLDR
- Bloom Energy shares plummeted up to 13% following a record high achieved just one day earlier
- Microsoft and Chevron unveiled plans for natural gas turbines to power a Texas data facility, indicating Bloom confronts legitimate rivals
- Federal authorities revealed $17.5 billion in financial backing for nuclear power development, introducing yet another competitive option
- Bloom’s latest quarterly results significantly exceeded projections ā posting $0.44 EPS versus $0.12 anticipated, alongside 130.4% year-over-year revenue growth
- Wall Street analysts maintain a “Moderate Buy” consensus with a $224.36 average price target, considerably beneath recent trading levels
Bloom Energy (BE) has experienced an extraordinary surge throughout 2026, soaring 275% year-to-date and reaching a record peak on June 22. Then Tuesday arrived.
Shares opened with a significant gap down on June 23, plunging from the previous session’s close of $345.85 to an opening price of $309.35. By early afternoon, the stock hovered near $322.97, with trading volume exceeding 2.4 million shares ā robust activity for a security averaging 10.6 million shares daily.
Two distinct developments prompted investors to reassess whether Bloom Energy’s dominance in powering AI data centers would face meaningful challenges.
First came the Chevron and Microsoft announcement. The corporations revealed a collaboration to deploy natural gas turbines for a West Texas data facility, with operations scheduled to commence in 2028 and extend across two decades. This represents a substantial long-term agreement ā one that excludes Bloom entirely.
The second development emerged from the U.S. Department of Energy, which unveiled $17.5 billion in loan authority designed to strengthen America’s nuclear infrastructure. The objective: initiate construction on 10 large-scale nuclear facilities before 2030.
While neither development directly undermines Bloom’s current operations, both communications delivered an identical theme ā the AI data center energy sector will feature multiple players, not a single dominant force.
Impressive Performance, Yet Valuation Concerns Mount
Bloom’s fundamental performance has been exceptional. The company’s latest quarterly disclosure (April 28) revealed $0.44 in earnings per share compared to analyst expectations of $0.12 ā a significant $0.32 outperformance. Revenue reached $751 million against forecasts of $540 million, representing 130.4% year-over-year expansion. For fiscal 2026, management projects EPS ranging from $1.85 to $2.25.
Such robust earnings expansion is undeniably compelling. However, the stock’s meteoric ascent creates valuation challenges. The Wall Street consensus price objective stands at $224.36 ā shares were trading more than 40% above this level before Tuesday’s decline.
Morgan Stanley maintains an “overweight” stance with a $310 price objective. JPMorgan similarly rates the stock “overweight” with a $267 target. Bernstein recently launched coverage with a “Market Perform” designation. Mizuho’s target stands at $285.
Corporate Insiders Offloading Shares
A noteworthy trend has been developing quietly: company insiders have been reducing positions. Director Mary K. Bush divested 25,000 shares at $266.96 on May 7. Insider Aman Joshi sold 10,000 shares at $135.88 on April 1. Throughout the previous quarter, insiders collectively disposed of 230,274 shares valued at approximately $58.7 million.
Institutional stakeholders continue controlling 77% of outstanding shares, with multiple funds establishing new positions during Q1.
The stock’s beta coefficient of 3.74 underscores the extreme price fluctuations characteristic of this security ā volatility that persists.
As of Tuesday afternoon, BE traded around $340.77, declining roughly 5.2% for the session, with a market capitalization of $92 billion.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
